X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

GSK to provide meningitis B vaccine in UK

Yuvraj_pawp by Yuvraj_pawp
30th March 2015
in Europe, News

GlaxoSmithKline (GSK) has entered an agreement with the UK’s Department of Health to provide meningitis B vaccine for babies in the country.

 

Meningitis B is a bacterial infection that mostly affects children under the age of one and is common in children under five years of age. It will also affect teenagers aged between 15 and 19 years.

 

The vaccine will be provided through the NHS immunisation schedule, which was acquired from Swiss pharmaceutical firm Novartis in March this year.

 

The Bexsero vaccine against meningitis B was acquired from Novartis under the $20bn three-part transaction, excluding flu vaccines. “The vaccine will be first given to the babies at two months old under the national childhood immunisation scheme.”

 

GSK said that the deal will provide a fair value for the NHS and allows a reasonable return for the company to continue to invest in creating new treatments and vaccines.

 

The vaccine will be first given to the babies at two months old under the national childhood immunisation scheme, and later will receive two doses.

 

UK Health Secretary Jeremy Hunt said that Britain would be the first country across the world to introduce a nationwide meningitis B vaccination programme.

 

He further added that although it was disappointing for taking long time to sign the deal, but it was important to agree a price that was cost-effective for the NHS.

 

Novartis earlier had differences with the UK Government over the price of the vaccine, after the government received an advice from independent experts that the vaccine should be given to all babies over two months old through the National Health Service.

Tags: Europe
Previous Post

Multisorb to Attend Interphex 2015

Next Post

Ireland's Horizon Pharma to buy Hyperion for $1.1bn

Related Posts

Clinical Trials

Bio-Rad to Acquire Stilla Technologies by Q3 2025

28th February 2025
News

Types of Pharmaceutical Waste and How to Dispose of Them

31st December 2024
Developing Pharma Skills With Life Sci For Growth Initiative
News

UK Medicine Manufacturing Regulatory Framework For Care

6th November 2024
News

Nanoemulsion Drug Delivery Enhances Tuberculosis Care

6th November 2024
News

The Future of Drug Delivery Systems In Modern Medicine

6th November 2024
Revolutionizing Drug Discovery With AI For A Greener Future
News

AI and Nanotech Innovations in Advancing Drug Discovery

5th November 2024
Next Post

Micromeritics Announces Instrument Grant to the Massachusetts Institute of Technology

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In